Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million ...

Get the latest Recursion Pharmaceuticals, Inc. (RXRX) stock news and headlines to help you in your trading and investing decisions.